Pure Global

IVD Department qualitative and quantitative β-hCG testing - Vietnam Registration 240002607/PCBB-HN

Access comprehensive regulatory information for IVD Department qualitative and quantitative β-hCG testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002607/PCBB-HN. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
2 Recent Registrations
240002607/PCBB-HN
Registration Details
Vietnam MOH Registration: 240002607/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department qualitative and quantitative β-hCG testing
VN: Bộ IVD xét nghiệm định tính và định lượng β-hCG
Risk Class TBYT Loại B

Registration Details

240002607/PCBB-HN

000.00.19.H26-240910-0015

Theo theo phụ lục

Theo phụ lục

Technical Details

ARCHITECT Total β-hCG Calibrators are used to calibrate the ARCHITECT iSystem when performing qualitative and quantitative analysis of the membrane-bound beta-hCG (β-hCG) in human serum and plasma. Refer to the specific Architect Assay User Manual for more information. ARCHITECT Total β-hCG Controls are used in quality control to monitor the accuracy and precision of the ARCHITECT Total β-hCG test in human serum or plasma samples. Refer to the Architect Total β-hCG Assay User Manual and the Architect System Operation Manual for more information. ARCHITECT Total β-hCG is a Fluorescence Immunoassay (CMIA) test for the quantitative and qualitative analysis of the membrane-bound beta-hCG (β-hCG) in human serum and plasma to detect early pregnancy.

Dates and Status

Oct 02, 2024

Companies Making Similar Products
Companies providing products similar to "IVD Department qualitative and quantitative β-hCG testing"